CAS 583037-91-6

EC-17

Description:

EC-17, with the CAS number 583037-91-6, is a chemical compound that has garnered attention in various fields, particularly in research and development. It is characterized as a synthetic compound with specific structural and functional properties that make it suitable for applications in areas such as pharmaceuticals or materials science. The compound typically exhibits stability under standard conditions and may possess unique reactivity profiles, which can be influenced by its molecular structure. Additionally, EC-17 may demonstrate specific solubility characteristics, allowing it to interact effectively with other substances in solution. Its safety profile, including toxicity and environmental impact, is crucial for its handling and application. As with many chemical substances, understanding its behavior in different environments, including its interactions with biological systems, is essential for determining its potential uses and regulatory considerations. For detailed information regarding its specific applications, safety data, and regulatory status, consulting specialized databases or scientific literature is recommended.

EC-17 free acid

CAS: 583037-91-6

EC17 is Folate-FITC, fluoresces at 500nm, targets FRα, and may have anticancer properties.

Formula: C₄₂H₃₆N₁₀O₁₀S

Purity: 98%

Color and Shape: Solid

Molecular weight: 872.87

Ref: TM-T25358

EC 17

CAS: 583037-91-6

EC 17 is a biological treatment that emits light. It has been shown to have an effect on tumor cells and to increase the immune system's response to cancer. EC 17 activates the antitumor response in various types of cancer cells, including breast, prostate, and colon cancers. EC 17 also exhibits antimicrobial resistance against bacteria such as E. coli and Staphylococcus aureus. The mechanisms of action are not fully understood, but it may be due to its ability to inhibit transcription or DNA replication by binding to bacterial DNA-dependent RNA polymerase or topoisomerase I. EC 17 has been shown to have an effect on symptoms in humans with rheumatoid arthritis when used as an adjuvant therapy for methotrexate treatment. This drug has also been tested in vitro and has been found to inhibit the growth of many types of cancer cells and bacteria, including Mycobacterium tuberculosis.

Formula: C₄₂H₃₆N₁₀O₁₀S

Purity: Min. 95%

Molecular weight: 872.9 g/mol

Ref: 3D-IYA03791